SH
SOSV's HAX
Newark, New Jersey, United StatesFounded 2011
SOSV's HAX invests in pre-seed and seed-stage "hard tech" startups that tackle complex problems in human and planetary health, spanning areas like industrial automation, climate tech, and advanced manufacturing. Their strategy involves hands-on support, providing capital, extensive engineering resources, and a residency program to help founders rapidly prototype, de-risk technology, and achieve market traction.
40% of their portfolio is in Manufacturing. Their most common stage is series-a (80% of deals). Average disclosed round size is $11.7M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$1.5B
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| LLexxPluss Inc. | Series A | $10.7M | Mar 2023 |
 Smartex | Series A | $24.7M | Nov 2022 |
 Flow Neuroscience | Series A | $7.9M | Aug 2021 |
 Allozymes | Seed | $5M | Jul 2021 |
 Presso | Series A | $10M | — |
Top Co-Investors
Xora Innovation1 shared
Entrepreneur First1 shared
TI Platform1 shared
Khosla Ventures1 shared
Lightspeed Venture Partners1 shared
Build Collective1 shared
H&M Group1 shared
DCVC1 shared
Momenta1 shared
Fashion for Good1 shared
Uncork Capital1 shared
Cherubic Ventures1 shared
1517 Fund1 shared
AME Cloud1 shared
Pathbreaker Ventures1 shared
Incubate Fund1 shared
SBI Investment1 shared
Last updated: 16 April 2026